SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
The Leukemia & Lymphoma Society Release: Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia